uniQure QURE
NASDAQ QURE
$38.32 -4.44 (-10.38%)
At close: Sep 24, 2026 · 4:00 PM EDT

uniQure (QURE) Other Non Operating Income (2016 - 2026)

uniQure (QURE) posted Other Non Operating Income of -$16.0 million for Q2 2026, down 523.72% on a QoQ basis from $3.8 million in Q1 2026, and down 185.69% year-over-year from $18.6 million in Q2 2025.

Analysis

uniQure (QURE) Other Non Operating Income (2016 - 2026) Analysis & Trends

uniQure has reported Other Non Operating Income for 11 years, with the latest figure at -$16.0 million in Q2 2026.

  • On a quarterly basis, Other Non Operating Income fell 185.69% year-over-year to -$16.0 million in Q2 2026; TTM through Jun 2026 was -$18.7 million, a 207.09% decrease from a year earlier, with the FY2025 full-year figure at $26.1 million, up 348.7% from the prior year.
  • Other Non Operating Income was -$16.0 million for Q2 2026 at uniQure, down from $3.8 million in the prior quarter.
  • The five-year high for Other Non Operating Income was $19.4 million in Q2 2022, with the low at -$19.1 million in Q4 2022.
  • Average Other Non Operating Income over 5 years is $1.2 million, with a median of $561500.0 recorded in 2023.
  • The largest YoY upside for Other Non Operating Income was 3966.67% in 2024 against a maximum downside of 503.98% in 2024.
  • Over 5 years, Other Non Operating Income stood at -$19.1 million in 2022, then jumped by 120.66% to $3.9 million in 2023, then slumped by 503.98% to -$15.9 million in 2024, then surged by 104.7% to $749000.0 in 2025, then tumbled by 2232.18% to -$16.0 million in 2026.
  • The last three Other Non Operating Income figures came in at -$16.0 million (Q2 2026), $3.8 million (Q1 2026), and $749000.0 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn
10 uniQure 2.96 Bn 2.96 Bn 5.49 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -15.97 Mn
Mar 31, 2026 3.77 Mn
Dec 31, 2025 749,000.00
Sep 30, 2025 -7.22 Mn
Jun 30, 2025 18.64 Mn
Mar 31, 2025 7.17 Mn
Dec 31, 2024 -15.94 Mn
Sep 30, 2024 7.56 Mn
Jun 30, 2024 -989,000.00
Mar 31, 2024 -1.15 Mn
Dec 31, 2023 3.95 Mn
Sep 30, 2023 186,000.00
Jun 30, 2023 374,000.00
Mar 31, 2023 -2.37 Mn
Dec 31, 2022 -19.09 Mn
Sep 30, 2022 14.36 Mn
Jun 30, 2022 19.40 Mn
Mar 31, 2022 8.57 Mn
Dec 31, 2021 8.02 Mn
Sep 30, 2021 10.44 Mn
API Access

uniQure Other Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=QURE&period=max&api_key=YOUR_API_KEY